Title |
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro |
|---|---|
Involved |
Joseph Kauer (Verfasser)
Melanie Märklin (Verfasser) Martin Pflügler (Verfasser) Sebastian Hörner (Verfasser)
Clemens Hinterleitner (Verfasser)
Claudia Tandler (Verfasser) Gundram Jung (Verfasser) Helmut R. Salih (Verfasser) Jonas S. Heitmann (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Journal of cancer research and clinical oncology : official organ of the Deutsche Krebsgesellschaft 13.5.2022, Seite 1-13 |
Published |
2022 |
Language |
|
Country |
|
Topic |
|
Subject |
Oncology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2022071819003697596634 (URN) |
Record ID |
1262860067 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: